CTXR Financial Statements | Balance Sheet, Income & Cash Flow Analysis
The financial statements for CTXR (CTXR) provide a snapshot of revenue trends, balance-sheet strength, and cash flow quality. Reviewing these together helps investors evaluate earnings durability, capital structure, and whether operating cash flow supports long-term business growth.
See stock fair value and complete historical financials—premium unlocks deeper tables and metrics.
Financial Statements
Related peers
Compare More →| DARE Daré Bioscience, Inc. | $1.83 -1.08% |
| APLM Apollomics, Inc. | $13.60 -8.42% |
| MBRX Moleculin Biotech, Inc. | $2.62 +2.75% |
| R Ryder System, Inc. | $218.97 -1.38% |
| FBLG FibroBiologics, Inc. Common Stock | $1.32 -4.35% |
| ATHA Athira Pharma, Inc. | $6.75 -6.12% |
| Peer | Price | Change | Market Cap | PE | EPS | Div Yield (TTM) | Analyst Rating | Volume |
|---|---|---|---|---|---|---|---|---|
| DARE Daré Bioscience, Inc. | $1.83 | -1.08% | 17.42 M | -1.52 | -1.20 | 0.00% | Buy | 88 |
| APLM Apollomics, Inc. | $13.60 | -8.42% | 15.01 M | -0.51 | -26.64 | 0.00% | Buy | 100 |
| MBRX Moleculin Biotech, Inc. | $2.62 | +2.75% | 3.17 M | -0.09 | -28.42 | 0.00% | Buy | 54 |
| R Ryder System, Inc. | $218.97 | -1.38% | 8.63 B | 18.28 | 11.98 | 1.62% | Buy | 254 |
| FBLG FibroBiologics, Inc. Common Stock | $1.32 | -4.35% | 2.77 M | -0.16 | -8.40 | 0.00% | Buy | 339 |
| ATHA Athira Pharma, Inc. | $6.75 | -6.12% | 26.62 M | -0.70 | -9.67 | 0.00% | Hold | 70 |
Frequently Asked Questions
What are CTXR's latest financial results?
Review CTXR's latest balance sheet, income statement, and cash flow to understand its profitability, revenue trends, and financial health. These metrics are essential for evaluating short-term performance and long-term stability.
How has CTXR's revenue and net income changed over time?
Analyzing historical revenue and net income shows growth trends and business performance. Consistent growth indicates operational strength, while declines may signal challenges that investors should consider.
What is CTXR's cash flow situation and liquidity?
Cash flow statements reveal how CTXR generates and uses cash. Strong operating cash flow and sufficient liquidity suggest the company can fund operations, pay dividends, and handle debt effectively.
How does CTXR's financial performance compare to industry peers?
Comparing key metrics like revenue growth, profit margins, and debt levels with competitors helps investors assess whether CTXR is outperforming or lagging within its sector.
Are CTXR's financial statements showing sustainable profitability?
By analyzing margins, ROE, ROIC, and cash generation over multiple periods, investors can evaluate whether CTXR's profits are repeatable and supported by strong fundamentals.